Loading, please wait....jpg)
.jpg)
The Premier July 23, 2025 CE webinar will be held from 1 - 2 pm EST. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Specialty, Oncology, and ID Drugs: What is in the Pipeline? - The 2025 Update
Speaker: Liya Davydov, PharmD, BCPS, BCGP, Senior Director, Clinical Pharmacy Services, Continuum of Care, Premier Inc, Charlotte, NC
ACPE Universal Activity Number: 0122-0000-25-043-L01-P/T [0.1 CEU] [1 Contact Hr.]
Date: Jul 23, 2025 01:00 PM - 02:00 PM
Fee
CE Hours
CE Units
Registration closes on Jul 23, 2025 01:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
|
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
Objectives
- Describe growth trends of specialty/oncology agents in the pharmaceutical pipeline
- Identify notable agents that have been recently approved, are in the late stages of development, or are under regulatory review for infectious diseases indications
- Identify specialty drugs that are currently under regulatory review for select indications
- List oral oncology agents that are currently under regulatory review for various cancers
- Recognize parenteral oncology agents that are currently under regulatory review for various cancers
Speaker(s)/Author(s)
|
Liya Davydov, PharmD, BCPS, BCGP
|